Immunome 

Yahoo Finance • 23 days ago

Immunome GAAP EPS of -$0.65

* Immunome press release [https://seekingalpha.com/pr/20297808-immunome-reports-third-quarter-2025-financial-results-and-provides-business-update] (IMNM [https://seekingalpha.com/symbol/IMNM]): Q3 GAAP EPS of -$0.65. * As of September... Full story

Yahoo Finance • last month

First Week of December 19th Options Trading For Zscaler (ZS)

Investors in Zscaler Inc (Symbol: ZS) saw new options begin trading this week, for the December 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZS options chain for the new December 19th contr... Full story

Yahoo Finance • 4 months ago

ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment

- IsoBio, Inc. (IsoBio) is a U.S.-based radiotherapeutic development company focused on developing a broad pipeline of mAb-based radioisotope therapeutics, known as antibody-isotope conjugates (AICsTM), targeting both derisked and novel tu... Full story

Yahoo Finance • 2 years ago

INVESTIGATION ALERT: Halper Sadeh LLC Investigates KDNY, WMC, AJX, IMNM

NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 2 years ago

ALERT: The M&A Class Action Firm Continues Investigating the Merger – AEL, AJX, IMNM, SGTX

NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Se... Full story

Yahoo Finance • 2 years ago

Moore Kuehn Encourages IMNM, WMC, AEL, and AJX Investors to Contact Law Firm

NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mer... Full story

Yahoo Finance • 3 years ago

AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets

- Multi-year collaboration to identify up to 10 novel target-antibody pairs leveraging Immunome's Discovery Engine - Immunome to receive $30M upfront payment with potential for further platform access and option payments as well as develop... Full story

Yahoo Finance • 3 years ago

Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19

First study subject has been dosed in a single dose/dose escalation study of recently diagnosed COVID-19 patients Study will evaluate safety as the primary end point with pharmacokinetics (PK) and virology as secondary assessments EXTON,... Full story